Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8 vs 12 Weeks of Sofosbuvir-Ravidasvir in Chronic Hepatitis C
NCT04885855Phase 3Completed
- Start
- Mar 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ravidasvir in hepatitis C virus infection. Started Mar 2021; status: completed.
02
Drugs
ravidasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT04885855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885855.